Medical and Societal information from the Research Community
Number of Articles: 17,750,454 Number of Contributors: 57 Number of Queries: 12,901,611
Save this page: Save to http://del.icio.us Save to http://www.reddit.com Save to http://www.digg.com Save to Google Bookmarks Save to Yahoo! My Web  Send this page

  Login  or Create a Free Account
Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion.
Dorene M Rentz,Terri J Huh,Lisa M Sardinha,Erin K Moran,John A Becker,Kirk R Daffner,Reisa A Sperling,Keith A Johnson
 
Cognitive reserve among highly intelligent older individuals makes detection of early Alzheimer's disease (AD) difficult. We tested the hypothesis that mild memory impairment determined by IQ-adjusted norms is associated with single photon emission computed tomography (SPECT) perfusion abnormality at baseline and predictive of future decline. Twenty-three subjects with a Clinical Dementia Rating (CDR) score of 0, were reclassified after scores were adjusted for IQ into two groups, 10 as having mild memory impairments for ability (IQ-MI) and 13 as memory-normal (IQ-MN). Subjects underwent cognitive and functional assessments at baseline and annual follow-up for 3 years. Perfusion SPECT was acquired at baseline. At follow-up, the IQ-MI subjects demonstrated decline in memory, visuospatial processing, and phonemic fluency, and 6 of 10 had progressed to a CDR of 0.5, while the IQ-MN subjects did not show decline. The IQ-MI group had significantly lower perfusion than the IQ-MN group in parietal/precuneus, temporal, and opercular frontal regions. In contrast, higher perfusion was observed in IQ-MI compared with IQ-MN in the left medial frontal and rostral anterior cingulate regions. IQ-adjusted memory impairment in individuals with high cognitive reserve is associated with baseline SPECT abnormality in a pattern consistent with prodromal AD and predicts subsequent cognitive and functional decline.

KEYWORDS:
      
 ESRNexus is provided as a service by TrialStat Corporation. ESRNexus is a registered trademark of TrialStat Corporation. Copyright 2008. View a list of all articles here